person · Reporting owner
Spissinger Allan Horst
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Enertopia Corp.ENRT · Entity 8684 | CFO | January 15, 2025 | June 10, 2025 |
| Lexaria Bioscience Corp.LXRP · Entity 7641 | Chief Financial Officer | April 23, 2020 | April 23, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Enertopia Corp.
Report date January 15, 2025 · Filed June 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.20 · Expires 2027-08-18 | Direct | 50,000 |
Reported balance
After 2025-01-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-01-15 · Other · Disposed 950,000 · Balance 50,000 F1: 20 for 1 consolidation effective on January 15, 2025 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2028-06-06 | Direct | 175,000 |
Reported balance
After 2025-06-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-06 · Grant · Acquired 125,000 · Balance 175,000 |
Filing footnotes · ownership attribution and instrument terms
F1: 20 for 1 consolidation effective on January 15, 2025
Lexaria Bioscience Corp.
Report date April 23, 2020 · Filed April 23, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.32 · Expires 2025-04-23 | Direct | 650,000 |
Reported balance
After 2020-04-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-04-23 · Grant · Acquired 650,000 · Balance 650,000 |
| common sharesSEC Table I · non-derivative | Direct | 119,116 |
Reported balance
Holding disclosure · report date 2020-04-23 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 119,116 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2025 Filed Jun 10, 2025 19:22 UTC | Enertopia Corp. ENRT · Entity 8684 | GrantStock Options · Derivative | 125,000 | $0.15 Strike: $0.15 | $18,750.00 |
DisclosureSEC source: 0001708848-25-000002 · primary_doc.xml · derivative · entry 2 Spissinger Allan Horst · CIK 0001708848 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Shares · 125,000 shares Expires 2028-06-06 Read SEC document |
| January 15, 2025 Filed Jun 10, 2025 19:22 UTC | Enertopia Corp. ENRT · Entity 8684 | OtherStock Options · Derivative | 950,000 | $1.20 Strike: $1.20 | $1,140,000.00 |
DisclosureSEC source: 0001708848-25-000002 · primary_doc.xml · derivative · entry 1 Spissinger Allan Horst · CIK 0001708848 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 950,000 shares Expires 2027-08-18 F1 · derivative.exercise_price: 20 for 1 consolidation effective on January 15, 2025 F1 · date: 20 for 1 consolidation effective on January 15, 2025 F1 · shares: 20 for 1 consolidation effective on January 15, 2025 F1 · derivative.underlying_shares: 20 for 1 consolidation effective on January 15, 2025 Read SEC document |
| April 23, 2020 Filed Apr 23, 2020 16:49 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Grantstock options · Derivative | 650,000 | $0.00 Strike: $0.32 | $0.00 |
DisclosureSEC source: 0001708848-20-000001 · primary_doc.xml · derivative · entry 2 Spissinger Allan Horst · CIK 0001708848 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,000 Underlying: common shares · 650,000 shares Expires 2025-04-23 Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 18:23 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Otherstock options · Derivative | 300,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001348362-20-000004 · primary_doc.xml · derivative · entry 7 Spissinger Allan Horst · CIK 0001708848 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 300,000 shares Expires 2023-05-31 F1 · kind: Cancellation of Options Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 18:23 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Otherstock options · Derivative | 200,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001348362-20-000004 · primary_doc.xml · derivative · entry 6 Spissinger Allan Horst · CIK 0001708848 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: common shares · 200,000 shares Expires 2022-12-01 F1 · kind: Cancellation of Options Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 18:23 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Otherstock options · Derivative | 150,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001348362-20-000004 · primary_doc.xml · derivative · entry 5 Spissinger Allan Horst · CIK 0001708848 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: common shares · 150,000 shares Expires 2022-06-01 F1 · kind: Cancellation of Options Read SEC document |
| February 15, 2019 Filed Feb 15, 2019 19:06 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Exercise / conversionStock Options · Derivative | 50,000 | $0.37 Strike: $0.37 | $18,500.00 |
DisclosureSEC source: 0001708848-19-000001 · primary_doc.xml · derivative · entry 6 Spissinger Allan Horst · CIK 0001708848 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,000 Underlying: Common Shares · 50,000 shares Expires 2022-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 15, 2019 19:06 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Exercise / conversioncommon shares | 50,000 | $0.37 | $18,500.00 |
DisclosureSEC source: 0001708848-19-000001 · primary_doc.xml · nonDerivative · entry 2 Spissinger Allan Horst · CIK 0001708848 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2018 Filed May 31, 2018 22:13 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantStock Options · Derivative | 300,000 | $1.53 Strike: $1.53 | $459,000.00 |
DisclosureSEC source: 0001708848-18-000001 · primary_doc.xml · derivative · entry 4 Spissinger Allan Horst · CIK 0001708848 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Shares · 300,000 shares Expires 2023-05-31 Read SEC document |
| December 01, 2017 Filed Dec 1, 2017 21:55 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantStock Options · Derivative | 200,000 | $0.83 Strike: $0.83 | $166,000.00 |
DisclosureSEC source: 0001103780-17-000005 · primary_doc.xml · derivative · entry 4 Spissinger Allan Horst · CIK 0001708848 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Shares · 200,000 shares Expires 2022-12-01 Read SEC document |
| December 01, 2017 Filed Dec 1, 2017 21:55 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 41,666 | $0.82 | $34,166.12 |
DisclosureSEC source: 0001103780-17-000005 · primary_doc.xml · nonDerivative · entry 2 Spissinger Allan Horst · CIK 0001708848 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,166 Read SEC document |
| June 01, 2017 Filed Jun 8, 2017 17:49 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantStock Options · Derivative | 200,000 | $0.38 Strike: $0.38 | $76,000.00 |
DisclosureSEC source: 0001708848-17-000001 · primary_doc.xml · derivative · entry 2 Spissinger Allan Horst · CIK 0001708848 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Shares · 200,000 shares Expires 2022-06-01 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.